News | July 30, 2025
Novartis India posts Q1 FY26 net profit at Rs. 27.62 Cr
Novartis India has reported total income of Rs. 98.16 crores during the period ended June 30, 2025
Novartis India has reported total income of Rs. 98.16 crores during the period ended June 30, 2025
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Kushwaha previously served as Chief Digital & Information Officer at Jubilant Ingrevia Limited
His career spans notable tenures at Syngene International Limited, Cipla, Nestlé, and Bharat Petroleum Corporation Limited
This case report is jointly authored by US clinicians from leading hospitals, Houston Methodist Hospital, Weill Cornell Medical College and Johns Hopkins
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
Carbamazepine Extended-Release Tablets are indicated for use as an anticonvulsant drug
The inspection was conducted from July 22-25, 2025
RPG Life Sciences has reported total income of Rs. 174.15 crores during the period ended June 30, 2025
This GMP certification for our sterile drug product manufacturing facility, Goa Plant II is a testament to our relentless efforts to supply quality and affordable medicines across geographies
Subscribe To Our Newsletter & Stay Updated
